Task: Answer the MCQ question.
Query: Which drug exhibits a -35.751% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1ccc(O)c(CP(=O)(c2ccccc2)c2ccccc2)c1
b CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
c CC(=O)NCCN=Cc1sc2ccccc2c1O
d O=C(Cc1ccccc1[N+](=O)[O-])N1CCN(S(=O)(=O)c2ccccc2)CC1
Answer: b. CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
4-[2-[(8-fluoro-5-propyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethyl]morpholine